The prognostic significance of programmed cell death protein 1 and its ligand on lymphoma cells and tumor-immune cells in diffuse large B-cell lymphoma, not otherwise specified
Authors
Teja Cas Slak
Department of Cytopathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Simona Miceska
Department of Cytopathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Gorana Gasljevic
Department of Pathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Maribor, Maribor, Slovenia
Lucka Boltezar
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Veronika Kloboves-Prevodnik
Department of Cytopathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Maribor, Maribor, Slovenia
Language: English
Page range: 99 - 109
Submitted on: Nov 7, 2023
Accepted on: Nov 25, 2023
Published on: Feb 21, 2024
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2024 Teja Cas Slak, Simona Miceska, Gorana Gasljevic, Lucka Boltezar, Veronika Kloboves-Prevodnik, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.